Nutritional immumomodulatory therapy in patients with gastric neoplasms: an Integrative Review
International Journal of Development Research
Nutritional immumomodulatory therapy in patients with gastric neoplasms: an Integrative Review
Received 27th October, 2021; Received in revised form 11th November, 2021; Accepted 26th December, 2021; Published online 30th January, 2022
Copyright © 2022, Bruno Vasconcelos Rodrigues et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This work consists of an integrative, exploratory-descriptive review, which aims to review the available evidence on the role of immunonutrition in the treatment of patients with surgical gastric cancer, being carried out through a retrospective survey of studies that raised data on immunonutrition and its attributions in patients with gastric cancer. The results of this study reveal that the use of immunomodulatory nutrients in people with gastric cancer undergoing gastrectomy showed beneficial effects, being able to positively modulate immunological, metabolic and inflammatory processes, contributing to the acceleration of the recovery process. However, there are still no conclusive results regarding its relationship with survival in the short, medium and long term. Bringing as conclusive precepts the importance of specific methodological tools in order to understand and confirm the properties of the studied compounds and their properties.